✦ LIBER ✦

Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial

✍ Scribed by Mads Ravnborg; Per Soelberg Sørensen; Magnus Andersson; Elisabeth G Celius; Peter J Jongen; Irina Elovaara; Emmanuel Bartholomé; Cris S Constantinescu; Karsten Beer; Ellen Garde; Bjørn Sperling

Book ID: 114409539
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 374 KB
Volume: 9
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(10)70132-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised double-blind placebo-controll

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

✍ George C Ebers 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 97 KB

NORdic trial of oral Methylprednisolone

NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial

✍ Per Soelberg Sorensen; Svein Ivar Mellgren; Anders Svenningsson; Irina Elovaara; 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 175 KB

Daclizumab in active relapsing multiple

Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta

✍ Daniel Wynn; Michael Kaufman; Xavier Montalban; Timothy Vollmer; Jack Simon; Jac 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 456 KB

Simvastatin as add-on therapy to interfe

Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial

✍ Per Soelberg Sorensen; Jan Lycke; Juha-Pekka Erälinna; Astrid Edland; Xingchen W 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 349 KB

Efficacy and safety of oral fumarate in

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

✍ Ludwig Kappos; Ralf Gold; David H Miller; David G MacManus; Eva Havrdova; Volker 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 209 KB

Effect of laquinimod on MRI-monitored di

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

✍ G Comi; A Pulizzi; M Rovaris; O Abramsky; T Arbizu; A Boiko; R Gold; E Havrdova; 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 143 KB